Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07989640
ABSTRACT:
Compounds are provided which are useful in the treatment of androgen receptor-associated conditions, such as age-related diseases, which compounds have the structurewhereinR1, R2and R4, are as defined herein;G is an aryl, heterocyclo or heteroaryl group, wherein said group is mono- or polycyclic, and which is optionally substituted;n is an integer of 1 or 2;m is an integer of 1 or 2;Z is oxygen (—O—) or NR4h;a prodrug ester, all stereoisomers thereof and a pharmaceutically acceptable salt thereof. A method for treating androgen receptor-associated conditions such as age-related diseases is also provided.
REFERENCES:
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3424749 (1969-01-01), Pfenninger
patent: 3948933 (1976-04-01), Fontanella
patent: 4036979 (1977-07-01), Asato
patent: 4411890 (1983-10-01), Momany et al.
patent: 4959361 (1990-09-01), Walser et al.
patent: 5179080 (1993-01-01), Rothkopf et al.
patent: 5403817 (1995-04-01), Sekinger
patent: 5482921 (1996-01-01), Seckinger et al.
patent: 5488064 (1996-01-01), Sher et al.
patent: 5491134 (1996-02-01), Sher et al.
patent: 5541204 (1996-07-01), Sher et al.
patent: 5556909 (1996-09-01), Desai
patent: 5605877 (1997-02-01), Schafer et al.
patent: 5612359 (1997-03-01), Merugesan et al.
patent: 5688808 (1997-11-01), Jones et al.
patent: 5688810 (1997-11-01), Jones et al.
patent: 5693646 (1997-12-01), Jones et al.
patent: 5693647 (1997-12-01), Jones et al.
patent: 5696127 (1997-12-01), Jones et al.
patent: 5696130 (1997-12-01), Jones et al.
patent: 5696133 (1997-12-01), Jones et al.
patent: 5770615 (1998-06-01), Cheng et al.
patent: 5776983 (1998-07-01), Washburn et al.
patent: 5811374 (1998-09-01), Bertram et al.
patent: 6011029 (2000-01-01), Ding et al.
patent: 6040321 (2000-03-01), Kim et al.
patent: 6043265 (2000-03-01), Merugusan et al.
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6310095 (2001-10-01), Sebti et al.
patent: 6365615 (2002-04-01), Kelly et al.
patent: 6531612 (2003-03-01), Gabriel et al.
patent: 6544987 (2003-04-01), Guo et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6586602 (2003-07-01), Thorsett et al.
patent: 6670386 (2003-12-01), Sun et al.
patent: 6710064 (2004-03-01), Launay et al.
patent: 6897225 (2005-05-01), Sircar et al.
patent: 6974823 (2005-12-01), Hamilton et al.
patent: 6992102 (2006-01-01), Hamann et al.
patent: 2002/0133004 (2002-09-01), Sekiyama
patent: 2004/0019063 (2004-01-01), Sun et al.
patent: 2004/0181064 (2004-09-01), Sun et al.
patent: 2005/0059652 (2005-03-01), Hamann et al.
patent: 82875/87 (1998-06-01), None
patent: 2126187 (1971-05-01), None
patent: 3809390 (1989-09-01), None
patent: 0272594 (1988-06-01), None
patent: 0493323 (1992-07-01), None
patent: 1004583 (2000-05-01), None
patent: 1125925 (2002-02-01), None
patent: 1503244 (1978-03-01), None
patent: 52083686 (1977-07-01), None
patent: WO8907110 (1989-08-01), None
patent: WO8907111 (1989-08-01), None
patent: WO9304081 (1993-03-01), None
patent: WO9405668 (1994-03-01), None
patent: WO9414817 (1994-07-01), None
patent: WO 96/19458 (1996-06-01), None
patent: WO9719086 (1997-05-01), None
patent: WO9721993 (1997-06-01), None
patent: WO9730992 (1997-08-01), None
patent: WO 97/49709 (1997-12-01), None
patent: WO9822461 (1998-05-01), None
patent: WO9825929 (1998-06-01), None
patent: WO9838192 (1998-09-01), None
patent: WO9854966 (1998-12-01), None
patent: WO9900353 (1999-01-01), None
patent: WO9901124 (1999-01-01), None
patent: WO9902224 (1999-01-01), None
patent: WO9902514 (1999-01-01), None
patent: WO9903848 (1999-01-01), None
patent: WO9907692 (1999-02-01), None
patent: WO9924416 (1999-05-01), None
patent: WO9927890 (1999-06-01), None
patent: WO9928324 (1999-06-01), None
patent: WO9943653 (1999-09-01), None
patent: WO9954318 (1999-10-01), None
patent: WO9954319 (1999-10-01), None
patent: WO9954330 (1999-10-01), None
patent: WO9965913 (1999-12-01), None
patent: WO9967252 (1999-12-01), None
patent: WO9967253 (1999-12-01), None
patent: WO0000485 (2000-01-01), None
patent: WO0001389 (2000-01-01), None
patent: WO0013508 (2000-03-01), None
patent: WO0059874 (2000-10-01), None
patent: WO0072845 (2000-12-01), None
patent: WO0107052 (2001-02-01), None
patent: WO0116108 (2001-03-01), None
patent: WO0116133 (2001-03-01), None
patent: WO0116139 (2001-03-01), None
patent: WO0130781 (2001-05-01), None
patent: WO 01/40185 (2001-06-01), None
patent: WO0146195 (2001-06-01), None
patent: WO0154498 (2001-08-01), None
patent: WO0170684 (2001-09-01), None
patent: WO0172705 (2001-10-01), None
patent: WO0218335 (2001-11-01), None
patent: WO0200653 (2002-01-01), None
patent: WO 02/074761 (2002-09-01), None
patent: WO03011824 (2003-02-01), None
patent: WO03066636 (2003-08-01), None
patent: WO 2005/032468 (2005-04-01), None
patent: WO 2005/087760 (2005-09-01), None
Choi, Chi. Use of Parallel-Synthesis Combinatorial Libraries for Rapid Identification of Potent FKBP12 Inhibitors. Bioorganic and Medicinal Chemistry Letters. 12 (2002) 1421-1428.
CAPLUS abstract of Guo, Chuangxing et al., WO 2001040185 A1, Accession No. 2001:416901.
Banz, W.J. et al., “Effects of Soy Protein and Soy Phytoestrogens on Symptoms Associated with Cardiovascular Disease in Rats”, Journal of Medicinal Food, vol. 2, Nos. 3-4, pp. 271-273 (1999).
Boeijen, A. et al., “Combinatorial Chemistry of Hydantoins”, Bioorganic & Medicinal Chemistry Letters, vol. 8, pp. 2375-2380 (1998).
Bourguet, W. et al., “Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α”, Nature, vol. 375, pp. 377-382 (1995).
U.S. Appl. No. 10/984,502, filed Nov. 9, 2004, Bi et al.
U.S. Appl. No. 10/048,437, filed Feb. 1, 2005, Nirschl et al.
U.S. Appl. No. 11/070,020, filed Mar. 2, 2005, Li et al.
U.S. Appl. No. 11/070,025, filed Mar. 2, 2005, Li et al.
U.S. Appl. No. 11/070,808, filed Mar. 2, 2005, Nirschl et al.
Brzozowski, A.M. et al., “Molecular basis of agonism and antagonism in the oestrogen receptor”, Nature, vol. 389, pp, 753-758 (1997).
Evans, R.M., “The Steroid and Thyroid Hormone Receptor Superfamily”, Science, vol. 240, pp. 889-895 (1988).
Grese, T.A. et al., “Molecular determinants of tissue selectivity in estrogen receptor modulators”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 14105-14110 (1997).
Hamann, L.G. et al., “Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6-(trifluoromethyl)-8-pyridona[5,6-g]-quinoline (LG121071)”, J. Med. Chem., vol. 42, No. 2, pp. 210-212 (1999).
Hamann, L.G. et al., “Synthesis and Biological Activity of a Novel Series of Nonsteroidal, Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridano[5,6-g]quinolines”, J. Med. Chem., vol, 41, No. 4, pp. 623-639 (1998).
Hempstock, J. et al., “Growth inhibition of prostate cell lines in vitro by phyto-oestrogens”, British Journal of Urology, vol. 82, pp. 560-563 (1998).
Neri, R. et al., “A Biological Profile of a Nonsteroidal Antiandrogen, SCH 13521 (4'-Nitro-3'-Trifluoromethylisobutyranilide)”, Endocrinology, vol. 91, No. 2, pp. 427-437 (1972).
Quella, S.K. et al., “Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial”, Journal of Clinical Oncology, vol. 18, No. 5, pp. 1068-1074 (2000).
Regal, J.F. et al., “Dietary Phytoestrogens Have Anti-Inflammatory Activity in a Guinea Pig Model of Asthma”, Proc. Soc. Exp. Biol. Med., vol. 223, pp. 372-378 (2000).
Shiau, A.K. et al., “The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen”, Cell, vol. 95, pp. 927-937 (1998).
Smigel, K., “Breast Cancer Prevention Trial Shows Major Benefit, Some Risk”, Journal of the National Cancer Institute, vol. 90, No. 9, pp. 647-648 (1998).
Tanenbaum, D.M. et al., “Crystallographic comparison of the estrogen and progesterone receptor's ligand binding
Bi Yingzhi
Hamann Lawrence G.
Manfredi Mark C.
Nirschl Alexandra A.
Sutton James C.
Anderson Rebecca
Bristol--Myers Squibb Company
Rodney Burton
Shterengarts Samantha
LandOfFree
Sulfonylpyrrolidine modulators of androgen receptor function... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylpyrrolidine modulators of androgen receptor function..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylpyrrolidine modulators of androgen receptor function... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725885